| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |